Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Country
- 🇨🇳China
- Ownership
- Joint Venture, Subsidiary
- Established
- 1997-04-16
- Employees
- -
- Market Cap
- -
- Website
- http://www.cttq.com
A Pharmacokinetic Study of Lanifibranor in Healthy Adult Chinese Subjects
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2024-01-02
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT06126562
- Locations
- 🇨🇳
The First Hospital of Jilin University, Changchun, Jilin, China
A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)
- First Posted Date
- 2023-11-08
- Last Posted Date
- 2023-12-21
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 78
- Registration Number
- NCT06122831
- Locations
- 🇨🇳
Tai'an City Central Hospital, Tai'an, Shandong, China
🇨🇳Central Hospital Of Minhang District, Shanghai, Shanghai, Shanghai, China
🇨🇳Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2023-11-03
- Last Posted Date
- 2023-11-03
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 135
- Registration Number
- NCT06116240
- Locations
- 🇨🇳
Jiangmen Central Hospital, Jiangmen, Guangdong, China
🇨🇳Affiliated Hospital of Hebei University, Baoding, Hebei, China
🇨🇳Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
A Clinical Trial of TQA3038 Injection in Healthy Adult Subjects
- Conditions
- Interventions
- First Posted Date
- 2023-10-16
- Last Posted Date
- 2023-12-05
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT06085053
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients
- Conditions
- Interventions
- First Posted Date
- 2023-09-25
- Last Posted Date
- 2023-09-29
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT06051565
- Locations
- 🇨🇳
Beijing Luhe Hospital, Capital Medical University, Beijing, Beijing, China
A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps
- Conditions
- Interventions
- First Posted Date
- 2023-09-14
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT06036927
- Locations
- 🇨🇳
Affiliated Zhongshan Hospital Of Dalian University, Dalian, Liaoning, China
🇨🇳The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
🇨🇳The First Affiliated Hospital of Xinjiang Medical University, Ürümqi, Xinjiang Uygur Autonomous Region, China
A Study to Evaluate Drug-Drug Interaction of TQ05105 Tablets
- Conditions
- Interventions
- First Posted Date
- 2023-09-06
- Last Posted Date
- 2023-09-06
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT06024915
- Locations
- 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China
A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.
- Conditions
- Interventions
- First Posted Date
- 2023-08-25
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 75
- Registration Number
- NCT06010901
- Locations
- 🇨🇳
Fuyang Cancer Hospital, Fuyang, Anhui, China
🇨🇳Fujian Cancer Hospital, Fuzhou, Fujian, China
🇨🇳Affiliated Hospital of Jining Medical University, Jining, Shandong, China
Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle
- Conditions
- Interventions
- First Posted Date
- 2023-08-24
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 4
- Registration Number
- NCT06010537
- Locations
- 🇨🇳
Xinxiang Central Hospital, Xinxiang, Henan, China
Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy
- Conditions
- Interventions
- First Posted Date
- 2023-08-23
- Last Posted Date
- 2023-09-06
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT06008405
- Locations
- 🇨🇳
Chongqing Hospital of Traditional Chinese Medicine, Chongqing, Chongqing, China
🇨🇳The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
🇨🇳Henan Cancer Hospital, Zhengzhou, Henan, China